Clover Health Investments Gross Margin 2020-2024 | CLOV

Current and historical gross margin for Clover Health Investments (CLOV) over the last 10 years. The current gross profit margin for Clover Health Investments as of December 31, 2024 is %.
Clover Health Investments Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-12-31 $1.37B $0.37B 26.62%
2024-09-30 $1.35B $0.33B 24.81%
2024-06-30 $1.32B $0.32B 24.45%
2024-03-31 $1.29B $0.29B 22.65%
2023-12-31 $1.26B $0.26B 20.32%
2023-09-30 $-0.53B $0.28B -52.35%
2023-06-30 $0.02B $0.23B 1255.56%
2023-03-31 $0.55B $0.14B 25.32%
2022-12-31 $1.10B $0.10B 9.48%
2022-09-30 $3.01B $0.01B 0.27%
2022-06-30 $2.58B $-0.02B -0.70%
2022-03-31 $2.15B $-0.05B -2.42%
2021-12-31 $1.47B $-0.08B -5.37%
2021-09-30 $1.21B $-0.08B -6.80%
2021-06-30 $0.95B $-0.05B -5.17%
2021-03-31 $0.71B $0.05B 7.07%
2020-12-31 $0.67B $0.08B 12.33%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.793B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.567B 53.27
Hims & Hers Health (HIMS) United States $11.630B 120.84
Tempus AI (TEM) United States $10.569B 0.00
Inspire Medical Systems (INSP) United States $4.461B 69.70
IRhythm Technologies (IRTC) United States $4.396B 0.00
Privia Health (PRVA) United States $3.035B 208.50
Enovis (ENOV) United States $1.887B 10.53
Schrodinger (SDGR) United States $1.746B 0.00
Phreesia (PHR) United States $1.506B 0.00
Azenta (AZTA) United States $1.223B 56.96
Omnicell (OMCL) United States $1.208B 21.31
10x Genomics (TXG) United States $1.073B 0.00
Fulgent Genetics (FLGT) United States $0.600B 0.00
Butterfly Network (BFLY) United States $0.551B 0.00
Talkspace (TALK) United States $0.509B 151.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.371B 827.00
Claritev (CTEV) United States $0.351B 0.00
Health Catalyst (HCAT) United States $0.290B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.136B 0.00
American Well (AMWL) United States $0.107B 0.00
Retrieve Medical Holdings (RMHI) United States $0.089B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
CareCloud (CCLD) United States $0.081B 3.07
111 (YI) China $0.068B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.060B 0.00
Outset Medical (OM) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00